| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $117,951 | 4 | 100 |
| Goldshleger Ilya | Chief Operating Officer | 0 | $0 | 1 | $14,205 | $-14,205 |
| Weinberg Eric | See remarks | 0 | $0 | 1 | $14,205 | $-14,205 |
| Kurtz Ronald M MD | Chief Medical Officer | 0 | $0 | 1 | $35,496 | $-35,496 |
| Wilterding Mark | Chief Financial Officer | 0 | $0 | 1 | $54,044 | $-54,044 |
As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual …
Over the last 12 months, insiders at RxSight, Inc. have bought $0 and sold $117,951 worth of RxSight, Inc. stock.
On average, over the past 5 years, insiders at RxSight, Inc. have bought $1.98M and sold $15.85M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,767 shares for transaction amount of $55,004 was made by Corley Jesse Anderson (director) on 2025‑01‑16.
| 2026-09-02 | Sale | Weinberg Eric | See remarks | 2,041 0.0049% | $6.96 | $14,205 | -30.58% | |
| 2026-09-02 | Sale | Goldshleger Ilya | Chief Operating Officer | 2,041 0.0049% | $6.96 | $14,205 | -30.58% | |
| 2026-09-02 | Sale | Kurtz Ronald M MD | Chief Medical Officer | 5,100 0.0122% | $6.96 | $35,496 | -30.58% | |
| 2026-09-02 | Sale | Wilterding Mark | Chief Financial Officer | 7,765 0.0186% | $6.96 | $54,044 | -30.58% | |
| 2025-03-12 | Sale | Fountain Tamara | director | 7,000 0.0171% | $25.71 | $180,002 | -63.10% | |
| 2025-01-22 | Sale | Maniar Shweta | director | 3,519 0.0085% | $30.87 | $108,618 | -61.67% | |
| 2025-01-16 | Corley Jesse Anderson | director | 1,767 0.0044% | $31.13 | $55,004 | -59.97% | ||
| 2025-01-15 | Corley Jesse Anderson | director | 1,443 0.0036% | $31.18 | $45,000 | -60.12% | ||
| 2024-11-29 | Sale | Goldshleger Ilya | See remarks | 3,105 0.0076% | $46.08 | $143,078 | -69.73% | |
| 2024-11-26 | Sale | Goldshleger Ilya | See remarks | 3,100 0.0077% | $45.88 | $142,228 | -69.18% | |
| 2024-11-26 | Sale | Maniar Shweta | director | 3,782 0.0093% | $45.88 | $173,518 | -69.18% | |
| 2024-11-22 | Sale | Goldshleger Ilya | See remarks | 3,100 0.0078% | $45.00 | $139,500 | -68.17% | |
| 2024-11-18 | Sale | Goldshleger Ilya | See remarks | 3,100 0.0078% | $45.00 | $139,502 | -67.64% | |
| 2024-11-15 | Sale | Goldshleger Ilya | See remarks | 4,875 0.0126% | $46.00 | $224,250 | -67.75% | |
| 2024-11-13 | Corley Jesse Anderson | director | 11,365 0.0284% | $44.92 | $510,491 | -67.32% | ||
| 2024-11-12 | Sale | Goldshleger Ilya | See remarks | 1,330 0.0033% | $46.13 | $61,356 | -67.82% | |
| 2024-11-12 | Corley Jesse Anderson | director | 11,111 0.0275% | $45.37 | $504,079 | -67.82% | ||
| 2024-11-07 | Sale | Goldshleger Ilya | See remarks | 3,100 0.0084% | $55.00 | $170,495 | -70.87% | |
| 2024-11-04 | Sale | Goldshleger Ilya | See remarks | 3,100 0.0077% | $51.05 | $158,247 | -70.86% | |
| 2024-10-30 | Sale | Goldshleger Ilya | See remarks | 3,105 0.0079% | $51.91 | $161,171 | -70.68% |
| Weinberg Eric | See remarks | 200348 0.4817% | $919,597.32 | 5 | 7 | <0.0001% |
| Goldshleger Ilya | Chief Operating Officer | 81509 0.196% | $374,126.31 | 1 | 37 | <0.0001% |
| Kurtz Ronald M MD | Chief Medical Officer | 71775 0.1726% | $329,447.25 | 2 | 5 | <0.0001% |
| Tammenoms Bakker Juliet | director | 34840 0.0838% | $159,915.60 | 5 | 10 | +12% |
| Andrews Julie | director | 30287 0.0728% | $139,017.33 | 1 | 1 | <0.0001% |
| LINK WILLIAM J PHD | director | 24248 0.0583% | $111,298.32 | 1 | 1 | <0.0001% |
| Corley Jesse Anderson | director | 3210 0.0077% | $14,733.90 | 6 | 2 | <0.0001% |
| Warner Robert Keith | director | 0 0% | $0 | 1 | 3 | <0.0001% |
| Increased Positions | 94 | +50.81% | 9M | +26.02% |
| Decreased Positions | 84 | -45.41% | 5M | -15.69% |
| New Positions | 36 | New | 4M | New |
| Sold Out Positions | 28 | Sold Out | 2M | Sold Out |
| Total Postitions | 195 | +5.41% | 37M | +10.34% |
| Blackrock, Inc. | $28,054.00 | 6.59% | 2.7M | -304,428 | -10.12% | 2025-09-30 |
| Millennium Management Llc | $22,764.00 | 5.35% | 2.19M | +1M | +130.56% | 2025-09-30 |
| Vanguard Group Inc | $22,286.00 | 5.24% | 2.15M | -131,406 | -5.77% | 2025-09-30 |
| D. E. Shaw & Co., Inc. | $19,036.00 | 4.47% | 1.83M | +512,561 | +38.79% | 2025-09-30 |
| Artisan Partners Limited Partnership | $18,203.00 | 4.28% | 1.75M | -498,861 | -22.15% | 2025-09-30 |
| No Street Gp Lp | $16,868.00 | 3.96% | 1.63M | +425,000 | +35.42% | 2025-09-30 |
| Citadel Advisors Llc | $13,392.00 | 3.15% | 1.29M | +262,281 | +25.52% | 2025-09-30 |
| Deutsche Bank Ag | $10,044.00 | 2.36% | 967,616 | -261,646 | -21.29% | 2025-09-30 |
| Bnp Paribas Financial Markets | $9,382.00 | 2.21% | 903,846 | +422,782 | +87.89% | 2025-09-30 |
| Morgan Stanley | $8,767.00 | 2.06% | 844,653 | -157,070 | -15.68% | 2025-09-30 |